Zobrazeno 1 - 7
of 7
pro vyhledávání: '"m-cll"'
Autor:
Lucie Poppova, Sarka Pavlova, Beatriz Gonzalez, Jana Kotaskova, Karla Plevova, Gabrijela Dumbovic, Pavlina Janovska, Vojtech Bystry, Anna Panovska, Lucie Bezdekova, Stanislava Maslejova, Yvona Brychtova, Michael Doubek, Marcela Krzyzankova, Marek Borsky, Jiri Mayer, Vitezslav Bryja, Sergio Alonso, Sarka Pospisilova
Publikováno v:
Epigenetics, Vol 17, Iss 12, Pp 1628-1635 (2022)
Genome methylation profiles define naïve-like (n-CLL), memory-like (m-CLL), and intermediate (i-CLL) subsets of chronic lymphocytic leukaemia (CLL). The profiles can be easily determined by the analysis of the five-CpG signature. m-CLL, i-CLL, and n
Externí odkaz:
https://doaj.org/article/2ac6200ffdb247bbae9278ab0e3327a5
Autor:
Arancha Rodríguez-Caballero, Blanca Fuentes Herrero, Guillermo Oliva Ariza, Ignacio Criado, Miguel Alcoceba, Carlos Prieto, María Pérez Caro, Andrés C. García-Montero, Marcos González Díaz, Francesco Forconi, Ana Bela Sarmento-Ribeiro, Julia Almeida, Alberto Orfao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The HCDR3 sequences of the B-cell receptor (BCR) undergo constraints in length, amino acid use, and charge during maturation of B-cell precursors and after antigen encounter, leading to BCR and antibodies with high affinity to specific antigens. Chro
Externí odkaz:
https://doaj.org/article/44b40bf1b99e40e4b16c5dfd3845b4f6
Autor:
Poppova, L, Pavlova, S, Gonzalez, B, Kotaskova, J, Plevova, K, Dumbovic, G, Janovska, P, Bystry, V, Panovska, A, Bezdekova, L, Maslejova, S, Brychtova, Y, Doubek, M, Krzyzankova, M, Borsky, M, Mayer, J, Bryja, V, Alonso, S, Pospisilova, S
Publikováno v:
Epigenetics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Genome methylation profiles define naive-like (n-CLL), memory-like (m-CLL), and intermediate (i-CLL) subsets of chronic lymphocytic leukaemia (CLL). The profiles can be easily determined by the analysis of the five-CpG signature. m-CLL, i-CLL, and n-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::0c4bfe3f9fe2b625a418988c8faf5867
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2532
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2532
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Multivariate statistics in the study of Chronic Lymphocytic Leukemia: genetics and epidemiology data
Autor:
Fuentes Escario, Daniel
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
La Leucèmia Limfocítica Crònica (LLC) és la leucèmia més comuna a Occident. Darrerament tres subtipus epigenètics de la malaltia han estat caracteritzats gràcies a la seva signatura epigenètica. A través de la integració de dades genètiqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d922dbbdc546a0a023353e195910c6d
http://hdl.handle.net/2117/134796
http://hdl.handle.net/2117/134796
Autor:
Poppova L; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Pavlova S; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Gonzalez B; IGTP-PMPPC: Program of Predictive and Personalized Medicine of Cancer, Germans Trias I Pujol Research Institute, Badalona, Spain., Kotaskova J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Plevova K; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Dumbovic G; IGTP-PMPPC: Program of Predictive and Personalized Medicine of Cancer, Germans Trias I Pujol Research Institute, Badalona, Spain.; Institute for Cardiovascular Regeneration, Center for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany., Janovska P; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic., Bystry V; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Panovska A; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Bezdekova L; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Maslejova S; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Brychtova Y; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Doubek M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Krzyzankova M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Borsky M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Mayer J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Bryja V; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic., Alonso S; IGTP-PMPPC: Program of Predictive and Personalized Medicine of Cancer, Germans Trias I Pujol Research Institute, Badalona, Spain., Pospisilova S; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Publikováno v:
Epigenetics [Epigenetics] 2022 Dec; Vol. 17 (12), pp. 1628-1635. Date of Electronic Publication: 2022 Mar 25.